Pharma in her DNA, Wockhardt scion ready for deep dive in the US
Duty relief may be extended for petrochemical inputs for pharma- Insider trading: Supreme Court upholds SAT clearance to Biocon MD
- SBI in $1 billion funding for Sun Pharma’s US deal
- FeaturedUTI Nifty 50 Index Direct-G-3.10-9.83-6.628.73
- -2.952.395.9321.57
- 3.56-3.65-1.6414.84
- Indian cancer patients battle shortage of key drugs as platinum costs surge
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide sales
- India willing to open its market to high-quality, innovative pharma products, says commerce minister
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits
- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak Securities
- Regulator, cos discuss price hike for some cancer drugs
- Drug companies directed to step up vigil on adverse reactions
- Manipal Health takes Bengaluru hospital building on long-term lease
- PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
- Warburg, KKR, TPG among PE giants vying for 25% stake in Cloudnine
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)
MORE NEWS
Biotech
GVK-backed Oval Fertility launched in Hyderabad, eyes share in India's growing IVF market- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker
- Biocon shifts focus to margins, capacity utilisation after expansion phase
- Kiran Mazumdar-Shaw picks niece Claire as successor at Biocon
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Healthcare
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak Securities
- PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
- Warburg, KKR, TPG among PE giants vying for 25% stake in Cloudnine
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Pharmaceuticals
- Pharma in her DNA, Wockhardt scion ready for deep dive in the US
- Duty relief may be extended for petrochemical inputs for pharma
- Insider trading: Supreme Court upholds SAT clearance to Biocon MD
- SBI in $1 billion funding for Sun Pharma’s US deal
- Indian cancer patients battle shortage of key drugs as platinum costs surge